Genentech to present over 40 abstracts highlighting advances in blood disorder therapies at ASH 2024 annual meeting
Genentech, a member of the Roche Group, announced that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology (ASH)… read more.
